Analyst Research

Report Title Price
Thomson Reuters Stock Report - CENTENE CORPORATION (CNC-N)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Trading Report for (CNC). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
$58.00
Buy
Centene Corporation (CNC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Provider: GlobalData
$250.00
Buy
The Investment Rate - a measure of investment demand.
Provider: Stock Traders Daily
$495.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Centene Corp Announces Dismissal Of Lawsuit


Monday, 24 Sep 2012 08:00am EDT 

Centene Corp announced that in June 2012, a putative class action lawsuit was filed in Federal Court against the Company and three of executives. The Company believes that the case was without merit and intended to vigorously defend its position. The plaintiff voluntarily dismissed the action without prejudice as to all claims and defendants. 

Latest Developments for Centene Corp

Latest Key Developments in Insurance

Company Quote

Centene Corp
(CNC.N)
50.77
0.28 +0.55%
21 May 2013